LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $20,000 | +150.0% | 11,800 | +18.0% | 0.00% | – |
Q4 2021 | $8,000 | +100.0% | 10,000 | -23.1% | 0.00% | – |
Q3 2021 | $4,000 | -63.6% | 13,000 | +5.7% | 0.00% | – |
Q2 2021 | $11,000 | -88.7% | 12,300 | -75.3% | 0.00% | -100.0% |
Q1 2021 | $97,000 | +15.5% | 49,700 | -48.8% | 0.01% | +150.0% |
Q4 2020 | $84,000 | +4100.0% | 97,000 | +634.8% | 0.00% | – |
Q3 2020 | $2,000 | -93.8% | 13,200 | -70.3% | 0.00% | -100.0% |
Q1 2020 | $32,000 | +6.7% | 44,500 | +22.3% | 0.00% | 0.0% |
Q4 2019 | $30,000 | +76.5% | 36,400 | -8.8% | 0.00% | +100.0% |
Q3 2019 | $17,000 | +240.0% | 39,900 | +110.0% | 0.00% | – |
Q2 2019 | $5,000 | +150.0% | 19,000 | +57.0% | 0.00% | – |
Q1 2019 | $2,000 | -99.9% | 12,100 | -96.2% | 0.00% | -100.0% |
Q4 2018 | $1,541,000 | +151.4% | 319,237 | +47.5% | 0.10% | +148.7% |
Q3 2018 | $613,000 | -73.9% | 216,462 | -48.3% | 0.04% | -64.9% |
Q3 2017 | $2,346,000 | +234500.0% | 418,978 | +4089.8% | 0.11% | – |
Q3 2016 | $1,000 | -80.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |